Keywords: humalog, implications, backing, eli, lilly, insulin, analog

Humalog Implications

Article | 11 March 1996

Print This

- The US backing of Eli Lilly's insulin analog Humalog (insulin lispro; see page 21) is "no threat" according to insulin producer ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in